Mitochondria deficient in complex I activity are depolarized by hydrogen peroxide in nerve terminals: relevance to Parkinson's disease - PubMed (original) (raw)
Mitochondria deficient in complex I activity are depolarized by hydrogen peroxide in nerve terminals: relevance to Parkinson's disease
C Chinopoulos et al. J Neurochem. 2001 Jan.
Free article
Abstract
Deficiency of complex I in the respiratory chain and oxidative stress induced by hydrogen peroxide occur simultaneously in dopaminergic neurones in Parkinson's disease. Here we demonstrate that the membrane potential of in situ mitochondria (Delta Psi m), as measured by the fluorescence change of JC-l (5,5',6,6'-tetrachloro-1,1,3,3'-tetraethylbezimidazolyl-carbocyani ne iodide), collapses when isolated nerve terminals are exposed to hydrogen peroxide (H(2)O(2), 100 and 500 microM) in combination with the inhibition of complex I by rotenone (5 nM-1 microM). H(2)O(2) reduced the activity of complex I by 17%, and the effect of H(2)O(2) and rotenone on the enzyme was found to be additive. A decrease in Delta Psi m induced by H(2)O(2) was significant when the activity of complex I was reduced to a similar extent as found in Parkinson's disease (26%). The loss of Delta Psi m observed in the combined presence of complex I deficiency and H(2)O(2) indicates that when complex I is partially inhibited, mitochondria in nerve terminals become more vulnerable to H(2)O(2)-induced oxidative stress. This mechanism could be crucial in the development of bioenergetic failure in Parkinson's disease.
Similar articles
- Depolarization of in situ mitochondria due to hydrogen peroxide-induced oxidative stress in nerve terminals: inhibition of alpha-ketoglutarate dehydrogenase.
Chinopoulos C, Tretter L, Adam-Vizi V. Chinopoulos C, et al. J Neurochem. 1999 Jul;73(1):220-8. doi: 10.1046/j.1471-4159.1999.0730220.x. J Neurochem. 1999. PMID: 10386974 - Inhibition of Krebs cycle enzymes by hydrogen peroxide: A key role of [alpha]-ketoglutarate dehydrogenase in limiting NADH production under oxidative stress.
Tretter L, Adam-Vizi V. Tretter L, et al. J Neurosci. 2000 Dec 15;20(24):8972-9. doi: 10.1523/JNEUROSCI.20-24-08972.2000. J Neurosci. 2000. PMID: 11124972 Free PMC article. - An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage.
Sherer TB, Betarbet R, Stout AK, Lund S, Baptista M, Panov AV, Cookson MR, Greenamyre JT. Sherer TB, et al. J Neurosci. 2002 Aug 15;22(16):7006-15. doi: 10.1523/JNEUROSCI.22-16-07006.2002. J Neurosci. 2002. PMID: 12177198 Free PMC article. - Ubiquinone (coenzyme q10) and mitochondria in oxidative stress of parkinson's disease.
Ebadi M, Govitrapong P, Sharma S, Muralikrishnan D, Shavali S, Pellett L, Schafer R, Albano C, Eken J. Ebadi M, et al. Biol Signals Recept. 2001 May-Aug;10(3-4):224-53. doi: 10.1159/000046889. Biol Signals Recept. 2001. PMID: 11351130 Review. - Complex I and Parkinson's disease.
Greenamyre JT, Sherer TB, Betarbet R, Panov AV. Greenamyre JT, et al. IUBMB Life. 2001 Sep-Nov;52(3-5):135-41. doi: 10.1080/15216540152845939. IUBMB Life. 2001. PMID: 11798025 Review.
Cited by
- Binding and release of cytochrome c in brain mitochondria is influenced by membrane potential and hydrophobic interactions with cardiolipin.
Piccotti L, Buratta M, Giannini S, Gresele P, Roberti R, Corazzi L. Piccotti L, et al. J Membr Biol. 2004 Mar 1;198(1):43-53. doi: 10.1007/s00232-004-0654-2. J Membr Biol. 2004. PMID: 15209096 - Diabetes-induced abnormalities of mitochondrial function in rat brain cortex: the effect of n-3 fatty acid diet.
Chomova M, Balazova M, Muchova J. Chomova M, et al. Mol Cell Biochem. 2017 Nov;435(1-2):109-131. doi: 10.1007/s11010-017-3061-6. Epub 2017 May 19. Mol Cell Biochem. 2017. PMID: 28526935 - AIF, reactive oxygen species, and neurodegeneration: a "complex" problem.
Polster BM. Polster BM. Neurochem Int. 2013 Apr;62(5):695-702. doi: 10.1016/j.neuint.2012.12.002. Epub 2012 Dec 12. Neurochem Int. 2013. PMID: 23246553 Free PMC article. Review. - Activation of Retinoid X Receptor increases dopamine cell survival in models for Parkinson's disease.
Friling S, Bergsland M, Kjellander S. Friling S, et al. BMC Neurosci. 2009 Dec 11;10:146. doi: 10.1186/1471-2202-10-146. BMC Neurosci. 2009. PMID: 20003337 Free PMC article. - Energetics and oxidative stress in synaptic plasticity and neurodegenerative disorders.
Mattson MP, Liu D. Mattson MP, et al. Neuromolecular Med. 2002;2(2):215-31. doi: 10.1385/NMM:2:2:215. Neuromolecular Med. 2002. PMID: 12428812 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical